Polyrizon files U.S. patent application for nasal drug delivery
uk.investing.com/news/stock-…
Investing.com $PLRZ
13
Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform
finance.yahoo.com/healthcare…
Yahoo Finance $PLRZ
45
Polyrizon Advances Nasarix Study With 3 Major US Trial Sites
marketscreener.com/news/poly…
$PLRZ
9
Polyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for NASARIX™ Trial
stocktitan.net/news/PLRZ/pol…
$PLRZ
5
Polyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for NASARIX™ Trial
finance.yahoo.com/sectors/he…
$PLRZ
4
Polyrizon signs first clinical trial agreement for allergy drug
investing.com/news/company-n…
$PLRZ
13
Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial
finance.yahoo.com/news/polyr…
$PLRZ
15
Polyrizon Signs an Agreement with Leading Global Preclinical CRO as Part of Clinical Development Program
finance.yahoo.com/news/polyr…
$PLRZ
15
Polyrizon Launches GMP Manufacturing for U.S. Clinical Trial
clinicaltrialvanguard.com/ne…
$PLRZ
9
Polyrizon reports nasal deposition study results for naloxone
investing.com/news/company-n…
@Investingcom $PLRZ
28
Polyrizon Study Finds Enhanced Nasal Deposition Profile for Proprietary Naloxone Formulation
geneonline.com/polyrizon-stu…
$PLRZ
16
Polyrizon Ltd. Reports Promising Results in Nasal Deposition Study for Naloxone Formulation
quiverquant.com/news/Polyriz…
$PLRZ
1
32
Polyrizon Intends to Secure Controlling Stake in Profitable Private Jet Operator
stocktitan.net/news/PLRZ/pol…
$PLRZ
13
Polyrizon to develop intranasal formulation of Clearmind’s MEAI
oindpnews.com/2026/02/polyri…
$PLRZ
18
Polyrizon partners with Clearmind to develop intranasal MEAI formulation
streetinsider.com/Corporate+…
$PLRZ @Street_Insider
17
Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation
stocktitan.net/news/PLRZ/pol…
$PLRZ @StockTitan_net
19
Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation
finance.yahoo.com/news/polyr…
$PLRZ
14

